Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions

Human Molecular Genetics

Volumn 20, Issue 18, 2011, Pages 3606-3619

  Tuller, Tamir ^a,b   Atar, Shimshi ^b   Ruppin, Eytan ^a   Gurevich, Michael ^a,b   Achiron, Anat ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN FOS; PROTEIN P53; SMAD3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; ARTICLE; CELL ADHESION; CELL DEATH; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC REGULATION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; RELAPSE; REMISSION;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROTEIN INTERACTION MAPS; PROTEINS;

EID: 80052194345     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr281     Document Type: Article

References (55)

1. Waxman, S.G. (1998) Demyelinating diseases-new pathological insights, new therapeutic targets. N. Engl. J. Med., 338, 323-325.
2. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) Multiple Sclerosis. N. Engl. J. Med., 343, 938-952.
3. Compston, A. and Coles, A. (2002) Multiple sclerosis. Lancet, 359, 1221-1231.
4. Compston, A. and Coles, A. (2008) Multiple sclerosis. Lancet, 372, 1502-1517.
5. Minagar, A., Jy, W., Jimenez, J.J. and Alexander, J.S. (2006) Multiple sclerosis as a vascular disease. Neurol. Res., 28, 230-235.
6. Salaman, M.R. (2003) A two-step hypothesis for the appearance of autoimmune disease. Autoimmunity, 36, 57-61.
7. Centola, M., Frank, M.B., Bolstad, A.I., Alex, P., Szanto, A., Zeher, M., Hjelmervik, T.O., Jonsson, R., Nakken, B., Szegedi, G. et al. (2006) Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool. Scand. J. Immunol., 64, 236-242.
8. Achiron, A., Gurevich, M., Friedman, N., Kaminski, N. and Mandel, M. (2004) Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann. Neurol., 55, 410-417.
9. Achiron, A., Gurevich, M., Snir, Y., Segal, E. and Mandel, M. (2007) Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis. Clin. Exp. Immunol., 149, 235-242.
10. Baranzini, S.E., Mousavi, P., Rio, J., Caillier, S.J., Stillman, A., Villoslada, P., Wyatt, M.M., Comabella, M., Greller, L.D., Somogyi, R. et al. (2005) Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol., 3, e2.
11. Gurevich, M., Tuller, T., Rubinstein, U., Or-Bach, R. and Achiron, A. (2009) Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med. Genomics, 2, 46.
12. Bomprezzi, R., Ringner, M., Kim, S., Bittner, M.L., Khan, J., Chen, Y., Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P.S. et al. (2003) Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet., 12, 2191-2199.
13. Whitney, A.R., Diehn, M., Popper, S.J., Alizadeh, A.A., Boldrick, J.C., Relman, D.A. and Brown, P.O. (2003) Individuality and variation in gene expression patterns in human blood. Proc. Natl Acad. Sci. USA, 100, 1896-1901.
14. Barnes, M.G., Aronow, B.J., Luyrink, L.K., Moroldo, M.B., Pavlidis, P., Passo, M.H., Grom, A.A., Hirsch, R., Giannini, E.H., Colbert, R.A. et al. (2004) Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic Elr+ chemokine genes relate to course of arthritis. Rheumatology (Oxford), 43, 973-979.
15. Mandel, M., Gurevich, M., Pauzner, R., Kaminski, N. and Achiron, A. (2004) Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol., 138, 164-170.
16. Kaizer, E.C., Glaser, C.L., Chaussabel, D., Banchereau, J., Pascual, V. and White, P.C. (2007) Gene expression in peripheral blood mononuclear cells from children with diabetes. J. Clin. Endocrinol. Metab., 92, 3705-3711.
17. Chaussabel, D., Pascual, V. and Banchereau, J. (2010) Assessing the human immune system through blood transcriptomics. BMC Biol., 8, 84.
18. McDonald, I. (1998) Diagnostic methods and investigation in multiple sclerosis. In Compston, A., Ebers, G., Lassmann, H., McDonald, I., Matthews, B. and Werkele, H. (eds), McAlpines' Multiple Sclerosis. 3rd edn.
19. Cosimo Prantera, B.I.K. (1996) Crohn's Disease. Informa Health Care.
20. Brewer, E.J., Giannini, E.H. and Person, D.A. (1982) Juvenile Rheumatoid Arthritis. Saunders.
21. Eisenbarth, G.S. (2004) Type 1 Diabetes: Molecular, Cellular and Clinical Immunology. Springer.
22. Lahita, R.G. (2003) Lupus: Systemic Erythematosus. Academic Press.
23. Rose, N.R. and Mackay, I.R. (2006) The Autoimmune Diseases. Academic Press.
24. Ó 'Moráin, C.A. (1991) Ulcerative Colitis. CRC Press.
25. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. (2002) Molecular Biology of the Cell, Garland Publishing Inc., New York.
26. Vogel, C., Abreu Rde, S., Ko, D., Le, S.Y., Shapiro, B.A., Burns, S.C., Sandhu, D., Boutz, D.R., Marcotte, E.M. and Penalva, L.O. (2010) Sequence signatures and MRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol., 6, 400.
27. Tuller, T., Kupiec, M. and Ruppin, E. (2007) Determinants of protein abundance and translation efficiency in S. Cerevisiae. PLoS Comput. Biol., 3, e248.
28. Scherer, A. (2009) Batch Effects and Noise in Microarray Experiments: Sources and Solutions. John Wiley & Sons.
29. Chuang, H.Y., Lee, E., Liu, Y.T., Lee, D. and Ideker, T. (2007) Network-based classification of breast cancer metastasis. Mol. Syst. Biol., 3, 140.
30. Rutherford, A. (2001) Introducing to ANOVA and ANCOVA: A GLM Approach. SAGE Publication Inc.
31. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc., 57, 289-300.
32. Oksenberg, J.R., Baranzini, S.E., Sawcer, S. and Hauser, S.L. (2008) The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet., 9, 516-526.
33. Chowdhury, D. and Sen, R. (2003) Transient Il-7/Il-7r signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements. Immunity, 18, 229-241.
34. Tani-ichi, S., Lee, H.C., Ye, S.K. and Ikuta, K. (2010) Accessibility control of TCR Vgamma region by STAT5. Int. Immunol., 22, 693-703.
35. Kim, K., Lee, C.K., Sayers, T.J., Muegge, K. and Durum, S.K. (1998) The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J. Immunol., 160, 5735-5741.
36. Girvan, M. and Newman, M.E. (2002) Community structure in social and biological networks. Proc. Natl Acad. Sci. USA, 99, 7821-7826.
37. Sarial, S., Shokrgozar, M.A., Amirzargar, A., Shokri, F., Radfar, J., Zohrevand, P., Arjang, Z., Sahraian, M.A. and Lotfi, J. (2008) IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis. Iran J. Allergy Asthma Immunol., 7, 37-40.
38. Schrijver, H.M., van As, J., Crusius, J.B., Dijkstra, C.D. and Uitdehaag, B.M. (2003) Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1RA production in multiple sclerosis. Mediators Inflamm., 12, 89-94.
39. Niino, M., Kikuchi, S., Fukazawa, T., Yabe, I., Sasaki, H. and Tashiro, K. (2001) Genetic polymorphisms of IL-1beta and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients. J. Neuroimmunol., 118, 295-299.
40. Achiron, A., Feldman, A., Mandel, M. and Gurevich, M. (2007) Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann. N Y Acad. Sci., 1107, 155-167.
41. Serhan, C.N., Ward, P.A. and Gilroy, D.A. (2010) Fundamentals of Inflammation. Cambridge University Press, New York.
42. Schwiebert, L.M. (2005) Chemokines, Chemokine Receptors, and Disease. Elsevier Academic Press, California.
43. Vyshkina, T., Sylvester, A., Sadiq, S., Bonilla, E., Perl, A. and Kalman, B. (2008) CCL genes in multiple sclerosis and systemic lupus erythematosus. J. Neuroimmunol., 200, 145-152.
44. Sun, D., Tani, M., Newman, T.A., Krivacic, K., Phillips, M., Chernosky, A., Gill, P., Wei, T., Griswold, K.J., Ransohoff, R.M. et al. (2000) Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage. J. Neuropathol. Exp. Neurol., 59, 1031-1043.
45. Okamoto, H., Katsumata, Y., Nishimura, K. and Kamatani, N. (2004) Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum., 50, 3731-3732.
46. Bonner, J.C., Badgett, A., Lindroos, P.M. and Osornio-Vargas, A.R. (1995) Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro. Am. J. Respir Cell Mol. Biol., 13, 496-505.
47. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33, 1444-1452.
48. McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C. et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol., 50, 121-127.
49. Rual, J.F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G.F., Gibbons, F.D., Dreze, M., Ayivi-Guedehoussou, N. et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature, 437, 1173-1178.
50. Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F.H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S. et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell, 122, 957-968.
51. Peri, S., Navarro, J.D., Amanchy, R., Kristiansen, T.Z., Jonnalagadda, C.K., Surendranath, V., Niranjan, V., Muthusamy, B., Gandhi, T.K., Gronborg, M. et al. (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res., 13, 2363-2371.
52. Xenarios, I., Salwinski, L., Duan, X.J., Higney, P., Kim, S.M. and Eisenberg, D. (2002) Dip, the database of interacting proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res., 30, 303-305.
53. Zhao, F., Xuan, Z., Liu, L. and Zhang, M.Q. (2005) Tred: a transcriptional regulatory element database and a platform for in silico gene regulation studies. Nucleic Acids Res., 33, D103-D107.
54. Dennis, G. Jr, Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C. and Lempicki, R.A. (2003) David: database for annotation, visualization, and integrated discovery. Genome Biol., 4, P3.
55. Pedhazur, E.J. (1997) Multiple Regression in Behavioral Research. Wadsworth Publishing